Osteopenia (Disorder) Recruiting Phase 2 Trials for Ergocalciferol (DB00153)

Also known as: Osteopenia / Osteopenia (morphologic abnormality) / Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0087613 (Osteopenia (Disorder))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell TransplantationPrevention